Skip to content

Chapters ENES DE

XExtension Codes
Substances
XM6S30Medicaments
XM5MU9Systemic antibiotics, anti-infectives or antiparasitics
Systemic antibiotics and antibacterials
Cephalosporins and other beta-lactam antibiotics

XM3XC6 category

Monobactams

2 subordinate codes

XM3DB8Aztreonam
XM9FE9Carumonam

Also indexed as

Monobactams

Nearby in Cephalosporins and other beta-lactam antibiotics

XM3WK4Antibiotic b-lactam
XM7TD6Antibiotic cephalosporin (group)
XM5J74Cefaloglycin
XM8J52Cefamycin antibiotic
XM01V2Cefpimizole
XM45T3Cefteram
XM0C25Cefuzonam
XM4HC8Cephalosporins

PreviousXM60V7 — Fourth-generation cephalosporins NextXM1JU9 — Carbapenems

Browse ICD-11

01Certain infectious or parasitic diseases
02Neoplasms
03Diseases of the blood or blood-forming organs
04Diseases of the immune system
05Endocrine, nutritional or metabolic diseases
06Mental, behavioural or neurodevelopmental disorders
07Sleep-wake disorders
08Diseases of the nervous system
09Diseases of the visual system
10Diseases of the ear or mastoid process
11Diseases of the circulatory system
12Diseases of the respiratory system
13Diseases of the digestive system
14Diseases of the skin
15Diseases of the musculoskeletal system or connective tissue
16Diseases of the genitourinary system
17Conditions related to sexual health
18Pregnancy, childbirth or the puerperium
19Certain conditions originating in the perinatal period
20Developmental anomalies
21Symptoms, signs or clinical findings, not elsewhere classified
22Injury, poisoning or certain other consequences of external causes
23External causes of morbidity or mortality
24Factors influencing health status or contact with health services
25Codes for special purposes
26Supplementary Chapter Traditional Medicine Conditions
VSupplementary section for functioning assessment
XExtension Codes
Histopathology
Dimensions of injury
Dimensions of external causes
Consciousness
Substances
Diagnosis code descriptors
Capacity or context
Health Devices, Equipment and Supplies
Extension codes of particular relevance to skin diseases
5 more
XM6S30Medicaments
XM9N55Substances, chiefly nonmedicinal
Allergens
XM6CH2Drugs primarily affecting the autonomic nervous system
XM7YD4Drugs used in addictive disorders
XM8014Antivertigo and motion sickness preparations
XM1950Agents primarily acting on smooth and skeletal muscles or the respiratory system
XM5MU9Systemic antibiotics, anti-infectives or antiparasitics
XM0QJ8Neuroprotective agents, not elsewhere classified
XM7BA9Analgesics, antipyretics or anti-inflammatory drugs
XM7452Antiepileptics or antiparkinsonism drugs
XM0HK5Antipsychotics [neuroleptics]
14 more
Systemic antibiotics and antibacterials
Antimycobacterials
Antifungal agents
Antiviral drugs
Antivenin, antivenom (sera), Immunoglobulin
Vaccines
Other specified systemic anti-infectives and antiparasitics
Antiprotozoal drugs
Anthelminthics
XM0MG9Amphenicols
Penicillins
XM9XT2Beta-lactamase inhibitors
Cephalosporins and other beta-lactam antibiotics
XM8SY8Sulfonamides and trimethoprim derivatives
Macrolides
XM7E36Lincosamides
XM69N7Streptogramins
Aminoglycosides
7 more
XM01V2Cefpimizole
XM45T3Cefteram
XM0C25Cefuzonam
XM4HC8Cephalosporins
XM67G9Cephalothin
XM2K88Clavulanic acid
XM9BE0First-generation cephalosporins
XM4DG8Second-generation cephalosporins
XM3FN8Third-generation cephalosporins
XM60V7Fourth-generation cephalosporins
XM3XC6Monobactams
XM1JU9Carbapenems
XM3QS2Ceftobiprole medocaril
XM2LW5Ceftaroline fosamil
XM7RT0Ceftolozane and beta-lactamase inhibitor
4 more
XM3DB8Aztreonam
XM9FE9Carumonam

International Classification of Diseases, Eleventh Revision (ICD-11), World Health Organization (WHO) 2019/2021, https://icd.who.int/browse11. Licensed under Creative Commons Attribution-NoDerivatives 3.0 IGO (CC BY-ND 3.0 IGO).

Release 2026-01. View this entity in the official WHO ICD-11 browser.

This page reproduces WHO classification content for reference. It is not medical advice and must not be used to diagnose or treat. For coding decisions, consult the official release and your national coding guidelines.

About · Data & methodology · Privacy · Contact